Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Amiodarone
Drug ID BADD_D00115
Description Amiodarone is a benzofuran derivative, anti-arrhythmic drug used commonly in a variety of settings.[A36817] Most known for its approved indication in life-threatening ventricular arrhythmias, it is also used off-label in the outpatient and inpatient setting for atrial fibrillation. Because of its ability to cause serious toxicity and possibly death, amiodarone use should be reserved for its approved indications, according to prescribing information.[L3561,L11265,L11286]
Indications and Usage Intravenously, for initiation of treatment and prophylaxis of frequently recurring ventricular fibrillation and hemodynamically unstable ventricular tachycardia in patients refractory to other therapy. Orally, for the treatment of life-threatening recurrent ventricular arrhythmias such as recurrent ventricular fibrillation and recurrent hemodynamically unstable ventricular tachycardia.
Marketing Status Prescription; Discontinued
ATC Code C01BD01
DrugBank ID DB01118
KEGG ID D02910
MeSH ID D000638
PubChem ID 2157
TTD Drug ID D0L5WM
NDC Product Code Not Available
Synonyms Amiodarone | Amiodarona | Amiodarone Hydrochloride | Hydrochloride, Amiodarone | Amiohexal | Aratac | Tachydaron | Corbionax | Cordarone | Amiodarex | Trangorex | Kordaron | Cordarex | L-3428 | L 3428 | L3428 | Ortacrone | Rytmarone | SKF 33134-A | SKF 33134 A | SKF 33134A | Amiobeta | Braxan
Chemical Information
Molecular Formula C25H29I2NO3
CAS Registry Number 1951-25-3
SMILES CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCCN(CC)CC)I
Chemical Structure
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Bradycardia02.03.02.0020.012203%Not Available
Bradykinesia17.01.02.004--Not Available
Bronchospasm10.01.03.012; 22.03.01.004--
Bundle branch block left02.03.01.007--Not Available
C-reactive protein increased13.09.01.0070.000595%Not Available
Cachexia08.01.01.009; 14.03.02.001; 16.32.03.0110.000388%Not Available
Cardiac arrest02.03.04.0010.001553%
Cardiac failure02.05.01.0010.004037%
Cardiac failure acute02.05.01.0050.000893%Not Available
Cardiac failure congestive02.05.01.0020.009822%Not Available
Cardio-respiratory arrest02.03.04.002; 22.02.06.007--Not Available
Cardiogenic shock02.05.01.003; 24.06.02.0060.003274%Not Available
Cardiomegaly02.04.02.0010.000543%Not Available
Cardiomyopathy02.04.01.0010.001488%Not Available
Cataract06.06.01.0010.005953%
Cellulitis11.02.01.001; 23.09.01.001--Not Available
Cerebellar ataxia08.01.02.006; 17.02.02.013--Not Available
Chest pain02.02.02.011; 08.01.08.002; 22.02.08.0030.025001%Not Available
Chest X-ray abnormal13.19.02.0010.000893%Not Available
Cholestasis09.01.01.0010.001786%Not Available
Chronic obstructive pulmonary disease22.03.01.0070.001087%Not Available
Circulatory collapse24.06.02.0010.000595%Not Available
Coagulopathy01.01.02.0010.000893%Not Available
Coma17.02.09.001--Not Available
Confusional state17.02.03.005; 19.13.01.001--
Congenital hypothyroidism03.09.03.001; 05.02.03.004; 14.11.01.0270.000893%Not Available
Constipation07.02.02.001--
Coordination abnormal17.02.02.0040.010417%Not Available
Corneal degeneration06.06.03.001--Not Available
Corneal deposits06.06.03.0020.005060%Not Available
The 3th Page    First    Pre   3 4 5 6 7    Next   Last    Total 17 Pages
ADReCS-Target
Drug Name ADR Term Target
Tip:  Drug Name  ADR Term  Protein  Variation  Gene